(Q36628377)

15 August 2017

1 reference

title

FOXP3+ regulatory T cells: Current controversies and future perspectives (English)

1 reference

15 August 2017

1 reference

15 August 2017

Fiona M Powrie

1 reference

15 August 2017

Elisabeth Suri-Payer

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

European Journal of Immunology

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

2832-2836

1 reference

Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

Molecular mechanisms underlying FOXP3 induction in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Imbalance of regulatory T cells in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

FOXP3: of mice and men.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

TGF-beta as a T cell regulator in colitis and colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Dysfunctional T regulatory cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Activated CD4+CD25+ T cells selectively kill B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636459

7 January 2021

Identifiers

DOI

10.1002/EJI.200636459

1 reference

15 August 2017

1 reference